JoAnn Hsu
Papers
1
Total Citations
1
H-Index
1
About
Dr. JoAnn Hsu is a leading urologic oncologist whose research focuses on improving outcomes for patients with muscle-invasive bladder cancer (MIBC), particularly through refining risk stratification and treatment personalization. Her major contributions center on addressing the critical challenge of clinical staging inaccuracies, which can lead to either undertreatment or overtreatment. In her highly cited work, she systematically identified clinical and pathological predictors of pathologic upstaging at radical cystectomy, stratifying patients by whether they received neoadjuvant chemotherapy. This research provides a vital framework for clinicians to better predict which patients are at highest risk for more advanced disease than initially detected, thereby guiding more informed decisions about aggressive therapy. By elucidating the prognostic significance of these staging discrepancies, Dr. Hsu’s work directly enhances surgical planning and oncologic management. Her findings are instrumental in advancing precision medicine for bladder cancer, helping to ensure that patients receive the most appropriate and effective treatment from the outset.
Research Focus
Key Achievements
Top Papers
- 1